Universal Clinical Codes & Terminology Search

Optical coherence tomography (OCT) of middle ear with interpretation and report; unilateral

Oncology (solid tumor) cell-free DNA and RNA by next-generation sequencing interpretative report for germline mutations clonal hematopoiesis of indeterminate potential and tumor-derived single-nucleotide variants small insertions/deletions copy number alterations fusions microsatellite instability and tumor mutational burden

Optical coherence tomography (OCT) of middle ear with interpretation and report; bilateral

Oncology (pan-solid tumor) next-generation sequencing analysis of tumor methylation markers present in cell-free circulating tumor DNA algorithm reported as quantitative measurement of methylation as a correlate of tumor fraction

Biomechanical mapping transvaginal with report

Oncology (solid tumor) cell-free circulating DNA targeted genomic sequence analysis panel of 84 genes interrogation for sequence variants aneuploidy-corrected gene copy number amplifications and losses gene rearrangements and microsatellite instability

Preventive behavior change online/electronic structured intensive program for prevention of diabetes using a standardized diabetes prevention program curriculum provided to an individual per 30 days

Obstetrics (fetal antigen noninvasive prenatal test) cell-free DNA sequence analysis for detection of fetal presence or absence of 1 or more of the Rh C c D E Duffy (Fya) or Kell (K) antigen in alloimmunized pregnancies reported as selected antigen(s) detected or not detected

Autologous adipose-derived regenerative cell therapy for scleroderma in the hands; adipose tissue harvesting isolation and preparation of harvested cells including incubation with cell dissociation enzymes removal of non-viable cells and debris determination of concentration and dilution of regenerative cells

Obstetrics (single-gene noninvasive prenatal test) cell-free DNA sequence analysis of 1 or more targets (eg CFTR SMN1 HBB HBA1 HBA2) to identify paternally inherited pathogenic variants and relative mutation-dosage analysis based on molecular counts to determine fetal inheritance of maternal mutation algorithm reported as a fetal risk score for the condition (eg cystic fibrosis spinal muscular atrophy beta hemoglobinopathies [including sickle cell disease] alpha thalassemia)

Autologous adipose-derived regenerative cell therapy for scleroderma in the hands; multiple injections in one or both hands

Oncology (cutaneous or uveal melanoma) circulating tumor cell selection morphological characterization and enumeration based on differential CD146 high molecular-weight melanoma-associated antigen CD34 and CD45 protein biomarkers peripheral blood

Ablative laser treatment non-contact full field and fractional ablation open wound per day total treatment surface area; first 20 sq cm or less

Oncology (solid tumor) circulating tumor cell selection morphological characterization and enumeration based on differential epithelial cell adhesion molecule (EpCAM) cytokeratins 8 18 and 19 CD45 protein biomarkers and quantification of estrogen receptor (ER) protein biomarker-expressing cells peripheral blood

Ablative laser treatment non-contact full field and fractional ablation open wound per day total treatment surface area; each additional 20 sq cm or part thereof (List separately in addition to code for primary procedure)

Oncology (solid tumor) circulating tumor cell selection morphological characterization and enumeration based on differential epithelial cell adhesion molecule (EpCAM) cytokeratins 8 18 and 19 CD45 protein biomarkers and quantification of PD-L1 protein biomarker-expressing cells peripheral blood

Contact near-infrared spectroscopy studies of lower extremity wounds (eg for oxyhemoglobin measurement)

Transplantation medicine quantification of donor-derived cell-free DNA (cfDNA) using next-generation sequencing plasma reported as percentage of donor-derived cell-free DNA

Surgical preparation and cannulation of marginal (extended) cadaver donor lung(s) to ex vivo organ perfusion system including decannulation separation from the perfusion system and cold preservation of the allograft prior to implantation when performed

Red blood cell antigen (fetal RhD gene analysis) next-generation sequencing of circulating cell-free DNA (cfDNA) of blood in pregnant individuals known to be RhD negative reported as positive or negative